Optional callout banner for highlighted news or events
Learn MoreIn this episode presented by PII, BioSpace’s head of insights discusses with guests Oliver Eden and Travis Webb how autoinjectors offer opportunities to improve delivery systems, patient compliance and clinical trial processes.
Clinical trials can present many challenges for patients–particularly injections.
Oliver Eden, senior business unit director at Jabil, and Travis Webb, chief scientific officer at PII, discuss nuance, challenges and opportunities of autoinjectors and combination drug delivery systems.
Additionally, they advocate that drug delivery systems enter the conversation earlier in clinical development stages given interdependencies.